Please login to the form below
infectious diseases
This page shows the latest infectious diseases news and features for those working in and with pharma, biotech and healthcare.
Merck buys Themis as part of drive for COVID-19 drugs and vaccines
Deal also adds a pipeline of vaccines for other infectious diseases as well as cancer. ... The company hasn’t disclosed how much it is paying for Themis, which also adds a pipeline of vaccines for other infectious diseases as well as cancer.
Latest news
-
Moderna’s coronavirus vaccine hits first objectives
Shares in the US biotech spiked around 23% after the data emerged from the study, which was led by scientists at the US National Institute of Allergy and Infectious Diseases (NIAID).
-
Covidian selection
Some smaller things seem obvious. For example, our pre-COVID environment was one that took infectious diseases quite lightly. ... This will be most obvious with respect to infectious diseases but it will have a wider effect too.
-
Potential universal flu vaccine shows efficacy in clinical trial
Amesh Adalja, an infectious-diseases specialist and senior scholar at Johns Hopkins Center for Health Security.
-
US Department of Health and Human Services calls for coronavirus product proposals
The first batch of Moderna’s vaccine was sent to the NIH and the National Institute of Allergy and Infectious Diseases (NIAID) for testing in a planned phase 1 study.
-
Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in US
Participants in the study, which is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), must have a laboratory-confirmed case of novel coronavirus – also known as COVID-19 –
More from news
Approximately 4 fully matching, plus 187 partially matching documents found.
Latest Intelligence
-
As COVID-19 takes over the world, biopharma fights back
I don’t think the ongoing trials will tell us a lot,” said H Clifford Lane, clinical director at the National Institutes of Allergy and Infectious Diseases (NIAID). ... IL-6 is a type of cytokine that plays an important role in immune response and is
-
We’ll need more than a spoonful of sugar to counter vaccine hesitancy
It is, therefore, critical that action is taken to stop the re-emergence of dangerous infectious diseases.
-
Biotech profile: Tom Evans, CEO, Vaccitech.
He moved to the University of Rochester as Associate Professor for 5 years, before becoming Infectious Diseases Division Chief and tenured full Professor at the University of California, Davis. ... In 2005, he joined the Novartis Institutes for
-
The threat of antimicrobial resistance
A study recently reported in The Lancet Infectious Diseases found that antibiotics are now failing to work in a fifth of patients who suffer an infection after hospital surgery.
-
Deal Watch February 2016
Alere has annual sales of approximately $2.5bn from a portfolio of point-of-care products in areas including cardiometabolic, infectious diseases such as HIV, malaria, syphilis, E. ... Pronutria's focus is on the development of therapeutics and
More from intelligence
Approximately 0 fully matching, plus 25 partially matching documents found.
Latest appointments
-
New hires at Bayer, Eisai and Accord Healthcare
Most recently, she held the position of vice president of M&A operations and divestitures and led the infectious diseases and vaccines business development. ... She joins Eisai from Merck, where she served as executive director, clinical quality assurance
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
and infectious diseases.
-
Nabriva Therapeutics appoints chief medical officer
Commenting on the appointment, Dr Colin Broom, chief executive officer of Nabriva, said: “Jennifer has broad expertise in infectious diseases and internal medicine with extensive experience in both clinical development and
-
Dr Jan van de Winkel joins Austrian biotech Hookipa
As Hookipa grows and progresses to become an integrated biotech company with multiple clinical programmes in infectious diseases and immune-oncology, Jan’s experience of building companies and his scientific insight
-
Emotive expands client services team
Biology graduate Rob Mackichan joins the agency as an account manager, bringing experience of working with infectious diseases, rare diseases and medical devices.
More from appointments
Approximately 0 fully matching, plus 36 partially matching documents found.
Latest from PMHub
-
Speakers Announced: Maintaining Market Access Continuity through a Global Pandemic Webinar
Professor Jean Paul Stahl, Professor of Infectious Diseases, University Hospital, Grenoble, France. ... Former President of the French Infectious Diseases Society. Edmund Pezalla, Former Vice President, National Medical Director, Pharmaceutical Policy
-
Lucid Group adds more magic to the mix with four new hires
Betty has worked on a wide variety of medical education initiatives in various therapeutic areas including immuno-oncology, infectious diseases, transplantation and multiple sclerosis. ... Katherine has a background in oncology, neurology, metabolic
-
Antibiotic resistance: The silent pandemic
In a globalised world, infectious diseases can travel long distances in relatively short periods of time, making the problem of resistance one that is relevant to all seven billion of us
-
UK vs US: what makes a successful immunisation programme?
Emily Macdonald calls on her experience as a public health nurse specialising in the prevention of infectious disease in both the US and UK, to explore the differences between immunisation programmes ... We understand infectious diseases so well that we
-
emotive adds to medical team with new Scientific Lead and Associate Medical Writer
Following a busy year and with a number of new Global and EMEA account wins including two pre-launch products for rare diseases, emotive has strengthened the medical team with the ... in rare diseases such as Gaucher disease and Cushing’s disease
More from PMHub
Approximately 1 fully matching, plus 12 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Regeneron says antibody for COVID-19 could be ready this year
- Amgen adds Otezla to the COVID-19 candidate list
- UK clears NHS use of Gilead’s remdesivir for COVID-19 patients
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- NICE approves Roche’s Tecentriq in TNBC after revising deal
- CEPI-backed coronavirus vaccine from Novavax starts trials
- IFPMA industry association conference: ‘no-one left behind’ on coronavirus vaccine
- Roche/Gilead tag team fights COVID-19 with Actemra/remdesivir
- GSK plans to produces one billion doses of vaccine adjuvant for COVID-19
- The big issue
- The field team are off the road! What should they do next?
- INFOGRAPHIC 02: The Importance of clinical study websites
PMHub
Weber Shandwick
At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...
Latest intelligence
- The big issue
- Whether you want to lead or follow, you need to understand the elephant in the C-suite...
- INFOGRAPHIC 02: The Importance of clinical study websites
- Here’s a infographic of why clinical study websites are important to patient recruitment and retention strategies…...
- Working with, Advocating for, and Empowering Patients
- A holistic view of how to work with patients virtually...
Quick links
Infographics
